UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Update on asthma control in five European countries: results of a 2008 survey

European respiratory review, 2010-06, Vol.19 (116), p.150-157

2010

Volltextzugriff (PDF)

3115 Real-world treatment patterns among patients with advanced non-small cell lung cancer in Europe: Evidence from a retrospective chart review in France, Germany, Italy and Spain

European journal of cancer (1990), 2015-09, Vol.51, p.S641-S641

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden

Value in health, 2014-11, Vol.17 (7), p.A642-A643

2014

Volltextzugriff (PDF)

Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

Value in health, 2013-11, Vol.16 (7), p.A594-A594

2013

Volltextzugriff (PDF)

Patient Count Projections for Advanced Melanoma by Line of Therapy and Other Clinical Characteristics in EU Countries: Results from The UK, Germany, France, Italy and Spain (EU-5)

Value in health, 2014-11, Vol.17 (7), p.A619-A619

2014

Volltextzugriff (PDF)

Conditional Survival (CS) Probabilities for Advanced Melanoma Patients Treated with Ipilimumab: Model Based Analysis

Value in health, 2013-11, Vol.16 (7), p.A398-A398

2013

Volltextzugriff (PDF)

Cost-Effectiveness Of Ipilimumab In Previously Treated Patients For Advanced Melanoma In Portugal

Value in health, 2013-05, Vol.16 (3), p.A139-A139

2013

Volltextzugriff (PDF)

An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial

Value in health, 2013-11, Vol.16 (7), p.A422-A422

2013

Volltextzugriff (PDF)

Costs of cardiovascular events of diabetic patients in the French hospitals

Diabetes & metabolism, 2007-09, Vol.33 (4), p.310-313

2007

Volltextzugriff (PDF)

PCN163 - Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden

Value in health, 2014-11, Vol.17 (7), p.A642-A643

2014

Volltextzugriff (PDF)

PRM107 - Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

Value in health, 2013-11, Vol.16 (7), p.A594-A594

2013

Volltextzugriff (PDF)

PCN35 - Conditional Survival (CS) Probabilities for Advanced Melanoma Patients Treated with Ipilimumab: Model Based Analysis

Value in health, 2013-11, Vol.16 (7), p.A398-A398

2013

Volltextzugriff (PDF)

PCN64 - Cost-Effectiveness Of Ipilimumab In Previously Treated Patients For Advanced Melanoma In Portugal

Value in health, 2013-05, Vol.16 (3), p.A139-A139

2013

Volltextzugriff (PDF)

Findings of a Literature Review in Support of a Patient Count Model (PCM) for Hepatitis C Virus (HCV) in the EU5

Value in health, 2016-11, Vol.19 (7), p.A409-A409

2016

Volltextzugriff (PDF)

PIN15 - Findings of a Literature Review in Support of a Patient Count Model (PCM) for Hepatitis C Virus (HCV) in the EU5

Value in health, 2016-11, Vol.19 (7), p.A409-A409

2016

Volltextzugriff (PDF)

PCN33 - Patient Count Projections for Advanced Melanoma by Line of Therapy and Other Clinical Characteristics in EU Countries: Results from The UK, Germany, France, Italy and Spain (EU-5)

Value in health, 2014-11, Vol.17 (7), p.A619-A619

2014

Volltextzugriff (PDF)

PCN170 - An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial

Value in health, 2013-11, Vol.16 (7), p.A422-A422

2013

Volltextzugriff (PDF)

Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism

Pediatric research, 1992-11, Vol.32 (5), p.600-604

1992

Volltextzugriff (PDF)

Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

ClinicoEconomics and outcomes research, 2017-01, Vol.9, p.163-172

2017

Volltextzugriff (PDF)

PRS29 QUALITY OF LIFE AND WORK PRODUCTIVITY IN ALLERGIC RHINITIS PATIENTS SUFFERING FROM BOTH NASAL AND OCULAR SYMPTOMS—AN OBSERVATIONAL, CROSS SECTIONAL STUDY IN 4 COUNTRIES IN EUROPE

Value in health, 2009, Vol.12 (7), p.A304-A304

2009

Volltextzugriff (PDF)

PRS30 IMPACT OF OCULAR SYMPTOMS ON RESOURCE UTILISATION AND WORK PRODUCTIVITY IN MANAGEMENT OF AR—AN OBSERVATIONAL, CROSS SECTIONAL STUDY IN 4 COUNTRIES IN EUROPE

Value in health, 2009, Vol.12 (7), p.A304-A304

2009

Volltextzugriff (PDF)

PRS9 QUALITY OF LIFE AND ECONOMIC IMPACT OF ASTHMA CONTROL IN FRANCE AND SPAIN. FIRST RESULTS OF THE EU-COAST STUDY

Value in health, 2010, Vol.13 (7), p.A320-A320

2010

Volltextzugriff (PDF)

PRS28 HAS ASTHMA CONTROL IMPROVED SINCE AIRE? RESULTS OF A SURVEY IN 5 EUROPEAN COUNTRIES

Value in health, 2008, Vol.11 (6), p.A454-A454

2008

Volltextzugriff (PDF)

PDB37 COSTS OF STAYS OF CARDIOVASCULAR EVENTS OF DIABETIC PATIENTS IN THE FRENCH HOSPITALS

Value in health, 2005-11, Vol.8 (6), p.A166-A166

2005

Volltextzugriff (PDF)

PRS31 A SURVEY OF THE BURDEN OF ALLERGIC RHINITIS IN EUROPE

Value in health, 2008, Vol.11 (6), p.A455-A455

2008

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Value In Health
(22)
Cancer Research
(4)
Physical Review Letters
(4)
הרפואה
(4)
Circulation
(3)
Nature Physics
(3)
Physical Review. B
(3)
Physical Review. B, Condensed Matter And Materials Physics
(3)
Cardiology
(2)
Infancy
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Update on asthma control in five European countries: results of a 2008 survey

3115 Real-world treatment patterns among patients with advanced non-small cell lung cancer in Europe: Evidence from a retrospective chart review in France, Germany, Italy and Spain

Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden

Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

Patient Count Projections for Advanced Melanoma by Line of Therapy and Other Clinical Characteristics in EU Countries: Results from The UK, Germany, France, Italy and Spain (EU-5)

Conditional Survival (CS) Probabilities for Advanced Melanoma Patients Treated with Ipilimumab: Model Based Analysis

Cost-Effectiveness Of Ipilimumab In Previously Treated Patients For Advanced Melanoma In Portugal

An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial

Costs of cardiovascular events of diabetic patients in the French hospitals

PCN163 - Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden

PRM107 - Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

PCN35 - Conditional Survival (CS) Probabilities for Advanced Melanoma Patients Treated with Ipilimumab: Model Based Analysis

PCN64 - Cost-Effectiveness Of Ipilimumab In Previously Treated Patients For Advanced Melanoma In Portugal

Findings of a Literature Review in Support of a Patient Count Model (PCM) for Hepatitis C Virus (HCV) in the EU5

PIN15 - Findings of a Literature Review in Support of a Patient Count Model (PCM) for Hepatitis C Virus (HCV) in the EU5

PCN33 - Patient Count Projections for Advanced Melanoma by Line of Therapy and Other Clinical Characteristics in EU Countries: Results from The UK, Germany, France, Italy and Spain (EU-5)

PCN170 - An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial

Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism

Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

PRS29 QUALITY OF LIFE AND WORK PRODUCTIVITY IN ALLERGIC RHINITIS PATIENTS SUFFERING FROM BOTH NASAL AND OCULAR SYMPTOMS—AN OBSERVATIONAL, CROSS SECTIONAL STUDY IN 4 COUNTRIES IN EUROPE

PRS30 IMPACT OF OCULAR SYMPTOMS ON RESOURCE UTILISATION AND WORK PRODUCTIVITY IN MANAGEMENT OF AR—AN OBSERVATIONAL, CROSS SECTIONAL STUDY IN 4 COUNTRIES IN EUROPE

PRS9 QUALITY OF LIFE AND ECONOMIC IMPACT OF ASTHMA CONTROL IN FRANCE AND SPAIN. FIRST RESULTS OF THE EU-COAST STUDY

PRS28 HAS ASTHMA CONTROL IMPROVED SINCE AIRE? RESULTS OF A SURVEY IN 5 EUROPEAN COUNTRIES

PDB37 COSTS OF STAYS OF CARDIOVASCULAR EVENTS OF DIABETIC PATIENTS IN THE FRENCH HOSPITALS

PRS31 A SURVEY OF THE BURDEN OF ALLERGIC RHINITIS IN EUROPE

Suchergebnisse filtern